Drugs / Insulin Actrapid
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT02370745 | Nov 2014 → Mar 2018 | muscular atrophy | University of Nottingham | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Insulin Actrapid | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02370745 ↗ |
| Route | Intravenous | “peripheral IV infusions of octreotide, insulin (Actrapid), 20% glucose, and mixed amino acids” PMID 36260533 ↗ Mar 2023 |